NASHVILLE, Tenn., March 28, 2017 -- SouthEast Eye Specialists and its affiliates (“SouthEast Eye Specialists”), a leading provider of medical and surgical eye care, and Center for Facial Rejuvenation, a leader in facial medical aesthetics, announced today that industry innovator James Pereyra has been appointed CEO of the companies. Mr. Pereyra spent the first 15 years of his career in aesthetics and dermatology, and more recently was President of NVISION Eye Centers, a leading provider of ophthalmology services.
“James’ unique background in ophthalmology as well as aesthetics make him a natural fit and perfect choice to lead both companies through the next stage of their development,” says Perry Ballard, Managing Director at Flexpoint Ford, a private equity firm that recently acquired both SouthEast Eye Specialists and Center for Facial Rejuvenation. “His dedication to healthcare services and experience in ophthalmology will be extremely valuable as we scale and grow regionally beyond Tennessee.”
“I’m excited for this opportunity to join the teams at SouthEast Eye Specialists and Center for Facial Rejuvenation, and contribute my industry knowledge and expertise to this dynamic partnership,” says Mr. Pereyra. “I look forward to partnering with our dedicated employees, doctors, and referring physicians to exceed our patients’ expectations.”
ABOUT FLEXPOINT FORD: Flexpoint Ford is a private equity firm dedicated to the healthcare and financial services sectors. Flexpoint Ford seeks to build relationships with executives and companies who look for Flexpoint Ford to be a value-added partner. Flexpoint Ford currently manages approximately $2.3 billion in committed capital on behalf of its limited partners. For more information, visit www.flexpointford.com or call (312) 327-4520.
ABOUT SOUTHEAST EYE SPECIALISTS: With locations throughout Tennessee, SouthEast Eye Specialists is the region's leading specialty eye center. Led by a team of highly trained, board certified professionals, SouthEast Eye Specialists is committed to providing exceptional patient care including cataracts and advanced lens replacement, corneal disease, glaucoma, eye muscle disorders, eyelid abnormalities, laser vision correction surgery, retinal surgery, and pediatric eye care. A physician-referral only practice, SouthEast Eye Specialists is entrusted by other doctors to care for patients with medical problems of higher complexity. For more information, visit www.southeasteye.com or call (877) 933-7337.
ABOUT CENTER FOR FACIAL REJUVENATION: Center for Facial Rejuvenation offers medically proven treatments and compassionate patient care to provide the best in skin care, laser treatments, and cosmetic procedures. Center for Facial Rejuvenation customizes treatments to meet individual patient goals, utilizing surgical and non surgical treatments such as BOTOX® and fillers, lasers, chemical peels and physician grade skincare products. For more information, visit www.chattanoogaface.com or call (423) 648-2035.


Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Meta Expands AI Training With Employee Activity Tracking Tools
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
SK Hynix to Invest $13 Billion in AI Chip Packaging Facility
Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 



